Cipatinib

DB16752InvestigationalSmall molecule

Cipatinib: Overview.

Mechanism: Pharmacologically active on Receptor tyrosine-protein kinase erbB-2 and Epidermal growth factor receptor
Curator reviewed

Resolves to

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cipatinib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.